What the new study found
Researchers from the University of Udine in Italy published a retrospective analysis in Emergency Radiology on August 31, 2026, examining whether iodinated contrast used during CT causes early or delayed kidney injury in critically ill adults. The team drew on MIMIC-IV, a large, de-identified critical care database built from intensive care admissions at Beth Israel Deaconess Medical Center, and applied a "target trial emulation" design — an approach meant to approximate the rigor of a randomized trial using observational data.
Out of 7,772 critically ill adults, 5,319 received contrast-enhanced CT and 2,453 received a non-contrast scan. Acute kidney injury occurred in 19.3% of the contrast group within 48 hours, versus 20.4% of the non-contrast group — numerically lower with contrast, and not a statistically meaningful difference either way.
The pattern held up across every other outcome the authors checked: no significant difference at 72 hours, no difference in cumulative AKI incidence at 7 days, no difference in time to first kidney injury, and — notably for clinicians worried about worst-case outcomes — no association between contrast exposure and the need for renal replacement therapy (dialysis) within 7 days. The authors do flag that residual confounding remains possible, since the database doesn't fully capture illness severity or the exact clinical reasoning behind each scan order.
Why the old caution took hold — and why it's been fading
"Contrast-induced nephropathy" became clinical dogma decades ago, much of it built on studies of intra-arterial contrast in cardiac catheterization and on observational data that lacked adequate control groups — meaning it was often impossible to tell whether kidney injury was caused by the contrast or simply coincided with it in patients who were already acutely ill.
That distinction matters because critically ill patients develop acute kidney injury at high rates regardless of what's injected into them — sepsis, hypotension, nephrotoxic medications, and the underlying illness itself are far more likely culprits. A 2020 consensus statement from the American College of Radiology and the National Kidney Foundation already concluded that the risk of IV iodinated contrast in patients with reduced kidney function has probably been overestimated, and that clinically indicated contrast-enhanced imaging should not be routinely delayed or withheld in stable patients with an eGFR of 30 mL/min/1.73m² or higher solely on nephropathy grounds. The new ICU-specific data extends that reassurance to a sicker, higher-acuity population where the caution has historically been strongest.
Contrast vs. no contrast, side by side
| Outcome | Contrast CT (n=5,319) | Non-contrast CT (n=2,453) |
|---|---|---|
| AKI within 48 hours | 19.3% | 20.4% |
| AKI within 72 hours | No significant difference | No significant difference |
| Cumulative AKI at 7 days | No significant difference | No significant difference |
| Dialysis need within 7 days | No association found | No association found |
The real cost of overcaution: non-diagnostic scans and repeat imaging
This is a distinct problem from reporting backlog. It happens earlier, at the ordering decision, before a study ever reaches a radiologist's worklist. When a clinician defaults to a non-contrast protocol — or delays a scan while waiting on a creatinine result — out of nephropathy concern, the resulting study can be non-diagnostic for the question it was meant to answer. Contrast is often required to reliably assess for pulmonary embolism, aortic dissection, active hemorrhage, abscess, or mesenteric ischemia: exactly the time-sensitive diagnoses most likely to come up in a critically ill patient.
A non-diagnostic scan doesn't just fail to answer the question — it usually means a second scan, hours later, after the delay has already cost time in a patient who may not have much to spare. Evidence like this new ICU cohort doesn't eliminate clinical judgment (unstable, hypovolemic patients or those on other nephrotoxic drugs still warrant individualized decisions), but it weakens the case for reflexive avoidance as a default.
Where xAID fits
Getting the right protocol ordered without unnecessary delay is one half of the time problem in acute imaging; what happens after the scan is acquired is the other, and it's a separate bottleneck — see our CT report turnaround-time benchmarks for how reporting delay compounds ordering delay. Once a contrast-enhanced CT is acquired, AI-assisted reporting produces a structured draft in minutes, xAID's in-house radiologist reviews every preliminary, and it reaches the reading radiologist ready-to-sign rather than sitting in a queue.
Frequently asked questions
What is contrast-induced nephropathy?
Contrast-induced nephropathy (CIN), also called contrast-associated acute kidney injury, refers to a decline in kidney function that was historically attributed to the iodinated contrast media used in CT scans. For decades it was treated as a major reason to withhold or delay contrast-enhanced imaging in patients thought to be at higher risk, including critically ill and renally impaired patients.
Does new research show iodinated contrast is safe for critically ill ICU patients?
A 2026 study in Emergency Radiology examined 7,772 critically ill adults in the MIMIC-IV critical care database, comparing 5,319 who received contrast-enhanced CT against 2,453 who received non-contrast CT. Acute kidney injury occurred in 19.3% of the contrast group versus 20.4% of the non-contrast group within 48 hours — not a statistically meaningful difference — and the groups also showed no significant difference at 72 hours, over 7 days cumulatively, or in need for renal replacement therapy (dialysis).
Should hospitals still withhold contrast for patients with reduced kidney function?
Society guidance already leans against routine withholding. A 2020 ACR–National Kidney Foundation consensus statement concluded that clinically indicated contrast-enhanced imaging should not be routinely delayed or withheld in stable patients with an eGFR of 30 mL/min/1.73m² or higher solely because of contrast-related kidney injury concerns. The new ICU data adds evidence for a more specific, higher-acuity population, though the study's authors note residual confounding is possible and individual clinical judgment still applies, particularly for unstable or hypovolemic patients.
How does nephropathy caution cause imaging delays?
When ordering clinicians default to a non-contrast protocol or delay a scan out of nephropathy concern, they can produce a study that cannot actually answer the clinical question — contrast is often required to assess for pulmonary embolism, aortic dissection, active bleeding, abscess, or mesenteric ischemia. That forces a repeat scan later or a delayed diagnosis, a decision made before the order ever reaches a radiologist's worklist.
Source: Orso et al., "Early and delayed acute kidney injury after contrast-enhanced CT in critically ill adults: a target trial emulation," Emergency Radiology (2026), DOI: 10.1007/s10140-026-02537-4, as reported by Radiology Business. Kidney-function guidance per the 2020 ACR–NKF consensus statement. MIMIC-IV database described in Johnson et al., Scientific Data (2023). Figures are rounded as reported.